NM_000158.4:c.1619-193C>T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000158.4(GBE1):​c.1619-193C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 151,806 control chromosomes in the GnomAD database, including 6,523 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.29 ( 6523 hom., cov: 32)

Consequence

GBE1
NM_000158.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0520

Publications

7 publications found
Variant links:
Genes affected
GBE1 (HGNC:4180): (1,4-alpha-glucan branching enzyme 1) The protein encoded by this gene is a glycogen branching enzyme that catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on the same or a neighboring glycogen chain. Branching of the chains is essential to increase the solubility of the glycogen molecule and, consequently, in reducing the osmotic pressure within cells. Highest level of this enzyme are found in liver and muscle. Mutations in this gene are associated with glycogen storage disease IV (also known as Andersen's disease). [provided by RefSeq, Jul 2008]
GBE1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to glycogen branching enzyme deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Laboratory for Molecular Medicine, Ambry Genetics, G2P, ClinGen
  • adult polyglucosan body disease
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-81537288-G-A is Benign according to our data. Variant chr3-81537288-G-A is described in ClinVar as [Benign]. Clinvar id is 1252926.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.423 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GBE1NM_000158.4 linkc.1619-193C>T intron_variant Intron 12 of 15 ENST00000429644.7 NP_000149.4 Q04446Q59ET0
GBE1XR_007095662.1 linkn.1747-193C>T intron_variant Intron 12 of 14

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GBE1ENST00000429644.7 linkc.1619-193C>T intron_variant Intron 12 of 15 1 NM_000158.4 ENSP00000410833.2 Q04446
GBE1ENST00000489715.1 linkc.1496-193C>T intron_variant Intron 12 of 15 2 ENSP00000419638.1 E9PGM4
GBE1ENST00000484687.1 linkn.20-193C>T intron_variant Intron 1 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.289
AC:
43791
AN:
151688
Hom.:
6516
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.346
Gnomad AMI
AF:
0.236
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.156
Gnomad EAS
AF:
0.437
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.232
Gnomad MID
AF:
0.247
Gnomad NFE
AF:
0.273
Gnomad OTH
AF:
0.268
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.289
AC:
43841
AN:
151806
Hom.:
6523
Cov.:
32
AF XY:
0.285
AC XY:
21138
AN XY:
74200
show subpopulations
African (AFR)
AF:
0.346
AC:
14346
AN:
41438
American (AMR)
AF:
0.268
AC:
4072
AN:
15214
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
541
AN:
3466
East Asian (EAS)
AF:
0.438
AC:
2246
AN:
5128
South Asian (SAS)
AF:
0.163
AC:
785
AN:
4824
European-Finnish (FIN)
AF:
0.232
AC:
2452
AN:
10566
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.273
AC:
18540
AN:
67856
Other (OTH)
AF:
0.272
AC:
573
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1607
3214
4821
6428
8035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.275
Hom.:
26247
Bravo
AF:
0.298
Asia WGS
AF:
0.290
AC:
1008
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jul 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.2
DANN
Benign
0.58
PhyloP100
-0.052
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2307058; hg19: chr3-81586439; API